Caers Jo, Van Valckenborgh Els, Menu Eline, Van Camp Benjamin, Vanderkerken Karin
Laboratory of Hematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium.
Bull Cancer. 2008 Mar;95(3):301-13. doi: 10.1684/bdc.2008.0600.
Cancerogenesis is believed to be a multistep process composed of different alterations that drive the transformation of normal human cells into highly malignant derivatives. These changes include self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, the evasion of programmed cell death, a limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Some evidence suggests that these cancer cells are derived from immature, proliferative precursors that feed the cancer cell compartment. Both, precursors and cancer cells, intensively interact with their surroundings, commonly described as their micro-environment. The processes above are also important in the biology of multiple myeloma, a malignant bone marrow disorder consisting of monoclonal plasma cells accumulation. In the current review we describe the biology of this disease, stressing the origin of myeloma cells, their acquired genetic changes and interactions with their bone marrow microenvironment.
癌症发生被认为是一个多步骤过程,由不同的改变组成,这些改变驱动正常人类细胞转变为高度恶性的衍生物。这些变化包括生长信号的自我充足、对生长抑制信号不敏感、逃避程序性细胞死亡、无限的复制潜能、持续的血管生成以及组织侵袭和转移。一些证据表明,这些癌细胞源自为癌细胞区室提供补充的未成熟增殖前体细胞。前体细胞和癌细胞都与它们的周围环境密切相互作用,通常将其周围环境描述为微环境。上述过程在多发性骨髓瘤(一种由单克隆浆细胞积聚组成的恶性骨髓疾病)的生物学中也很重要。在当前综述中,我们描述了这种疾病的生物学特性,重点强调骨髓瘤细胞的起源、其获得的基因变化以及与骨髓微环境的相互作用。
Trends Mol Med. 2010-2-16
Endocr Relat Cancer. 2010-1-29
Biochem Pharmacol. 2006-10-30
Eur J Cancer. 2006-7
Stem Cells. 1995-8
Eur J Cancer. 2009-9
Ann N Y Acad Sci. 2004-12
Nepal Med Coll J. 2005-6
Int J Mol Sci. 2021-8-21
Adv Pharm Bull. 2016-9
Oncol Lett. 2015-7